We developed two constructs desARE3'UTRERBB2-3 and 30, effective for destabilizing the ERBB2 transcript and degrading the protein, and ERBB2-dependent kinases WNK1, and YES1 in EGFR T790M NSCLC. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.